Vanda Pharmaceuticals Inc (VNDA.OQ)

VNDA.OQ on NASDAQ Stock Exchange Global Market

12.12USD
30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
$12.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
198,163
52-wk High
$19.25
52-wk Low
$5.74

VNDA.OQ

Chart for VNDA.OQ

About

Vanda Pharmaceuticals Inc. (Vanda) is a biopharmaceutical company. The Company is focused on the development and commercialization of products for the treatment of central nervous system disorders. The Company’s product portfolio includes tasimelteon, a compound for the treatment of circadian rhythm sleep disorders (CRSD), which... (more)

Overall

Beta: 1.86
Market Cap (Mil.): $471.48
Shares Outstanding (Mil.): 38.90
Dividend: --
Yield (%): --

Financials

  VNDA.OQ Industry Sector
P/E (TTM): -- 170.49 34.41
EPS (TTM): -1.69 -- --
ROI: -69.91 -1.91 17.37
ROE: -223.86 -7.10 18.18
Search Stocks

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,804 +147.00
Sumitomo Dainippon Pharma Co Ltd (4506.T) ¥1,288 -19.00
Pfizer Inc. (PFE.N) $29.84 +0.35
Merck & Co., Inc. (MRK.N) $57.31 +1.11
Sanofi SA (SASY.PA) €74.03 +2.12
AstraZeneca plc (AZN.L) 4,545.50p +45.50
Eli Lilly and Co (LLY.N) $66.80 +1.31

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks